findmyKOL

Zohar Sachs, MD, PhD

Basic profile

University of Minnesota

ORCIDNPI
RegionMinneapolis, MN · MidwestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Zohar Sachs is an Oncology physician affiliated with University of Minnesota. OpenAlex indexes 128 publications with 873 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
128publications

Distinct works indexed by OpenAlex, matched via ORCID.

873citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

420 Delaware St SE
Univ Of Mn Dept Of Medicine 14-154 Moos Mmc 286
Minneapolis, MN 554550341

Telephone

612-626-7055

Registry record last updated 9 Jan 2013.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    33.3%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor33.3%
    Acyclovir100%
    Part D11 patients
  • Cancer & immunology

    33.3%
    Kinase inhibitor22.8%
    Imbruvica54%Calquence46%
    Part D<11 patients
    Interferon alfa-2b10.5%
    Besremi100%
    Part D<11 patients
  • Anti-infectives

    22.8%
    Fluoroquinolone Antibacterial13.2%
    Levofloxacin100%
    Part D<11 patients
    Azole Antifungal9.6%
    Posaconazole100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”